McGuireWoods advised Vet’s Best Friend Group, a portfolio company of firm client Revelstoke Capital Partners, in its sale to Rarebreed Veterinary Partners. The deal adds 47 locations to Rarebreed’s 71-practice company to create one of the country’s largest veterinary practice groups.
The combined company, headquartered in Portland, Maine, is majority backed by Revelstoke and is one of the most well-capitalized veterinary health platforms in the United States. McGuireWoods also advised Revelstoke in its 2021 investment in Vet’s Best Friend Group, which helped provide significant liquidity to support the company’s expansion.
“We were pleased to assist Revelstoke and Vet’s Best Friend in this significant transaction, which positions the new combined company for future growth and success,” Costa said.
“We are proud of our longstanding relationship with Revelstoke Capital Partners and grateful for the confidence they place in our team,” Zahn added.
McGuireWoods consistently ranks among the leaders in U.S. and global M&A deals — including private equity transactions — in league tables published by Bloomberg and Refinitiv. McGuireWoods represents clients in all types of private equity deals, including leveraged buyouts, roll-ups, minority and junior capital investments, and independent sponsor transactions.